Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2010, for Innovative Acquisitions Corp. (Note: The input metadata references "PUMA BIOTECHNOLOGY, INC.", but the filing text explicitly identifies the registrant as Innovative Acquisitions Corp.). The company is a Delaware corporation classified as a "shell company" and a "blank check" company. It was formed to pursue a business combination through the acquisition of or merger with an operating business. As of the reporting date, the company has no specific business plan other than seeking a merger and has generated no revenue since its inception on April 27, 2007.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2010 | Six Months Ended June 30, 2009 | Cumulative (Inception to June 30, 2010) |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Net Loss | $(7,135) | $(10,216) | $(53,147) |
| Cash Balance (End of Period) | $1,803 | $2,437 | $1,803 |
| Total Assets | $1,803 | $2,408 (Dec 31, 2009) | $1,803 |
| Total Liabilities | $0 | $2,270 (Dec 31, 2009) | $0 |
| Net Cash Used in Operating Activities | $(9,405) | $(10,186) | $(53,147) |
| Net Cash Provided by Financing Activities | $8,800 | $12,550 | $54,950 |
| Shares Outstanding | 3,000,000 | 3,000,000 | 3,000,000 |
Liquidity: The company holds only cash assets ($1,803) and has no debt. It relies entirely on capital contributions from directors to fund operations.
Material Changes vs. Prior Period
- Net Loss Reduction: Net loss for the six months ended June 30, 2010, was $7,135, a decrease of approximately 30% compared to the $10,216 loss in the same period in 2009. This reduction is attributed to lower general and administrative expenses (legal, accounting, and audit fees).
- Liabilities Cleared: Total liabilities decreased from $2,270 (accounts payable) as of December 31, 2009, to $0 as of June 30, 2010.
- Cash Position: Cash decreased by $605 during the six-month period, dropping from $2,408 to $1,803, despite receiving $8,800 in capital contributions from directors.
Outlook, Risks, and Management Commentary
- Going Concern: Management explicitly states that the company has not generated revenue and is unlikely to do so in the immediate future. The continuation of the company is dependent on financial support from shareholders and the ability to obtain equity financing. These factors raise substantial doubt about the company's ability to continue as a going concern.
- Business Plan: The company intends to locate a suitable acquisition candidate. It does not restrict potential targets to any specific industry or location. Management anticipates incurring costs related to filing Exchange Act reports and investigating acquisitions over the next 12 months.
- Funding: The company expects to meet future costs through treasury funds, deferral of fees, or additional loans/investments from stockholders and management. A subsequent event noted in the filing indicates an additional $3,500 capital contribution was received from a director after June 30, 2010.
- Risks: Risks include the inability to find a target company, the financial instability of potential targets, and the lack of operating history. The company is a "shell company" with nominal assets and operations.
Investor Verification Checklist
- Capital Adequacy: Verify if the current cash balance ($1,803) is sufficient to cover filing fees and operational costs for the next 12 months without further dilution or director contributions.
- Related Party Transactions: Confirm the terms and necessity of continued capital contributions from directors, as the company relies entirely on these for survival.
- Acquisition Progress: Assess if there are any material agreements or discussions with potential target companies, as the filing indicates only general efforts to locate candidates.
- Going Concern Status: Review the latest filings to determine if the "substantial doubt" regarding the company's ability to continue as a going concern has been resolved.